Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis

被引:0
作者
Huang, Jinbao [1 ]
Weng, Heng [1 ]
Ye, Ling [1 ]
Jiang, Meiqin [1 ]
Chen, Lulu [1 ]
Li, Yangyu [2 ]
Li, Hongyan [3 ]
机构
[1] Fujian Univ Tradit Chinese Med, Dept Resp Med, Affiliated Peoples Hosp, Fuzhou, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Dept Clin Lab Med, Affiliated Peoples Hosp, Fuzhou, Peoples R China
[3] Fujian Univ Tradit Chinese Med, Dept Crit Care Med, Affiliated Peoples Hosp, Fuzhou, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2024年 / 14卷
关键词
pulmonary cryptococcosis; metagenomic next-generation sequencing; Cryptococcus neoformans; lung biopsy tissue; bronchoalveolar lavage fluid; PNEUMONIA; DNA;
D O I
10.3389/fcimb.2024.1446814
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) in pulmonary cryptococcosis (PC) using bronchoalveolar lavage fluid (BALF) and lung biopsy tissue specimens. Methods: In this retrospective study, 321 patients diagnosed with lower respiratory tract diseases who underwent mNGS using BALF and LBT samples, between January 2021 and December 2023 were included. Individuals were classified into PC and non-PC groups according to the diagnostic criteria for PC, and conventional fungal cultures were performed. A serum/BALF cryptococcal antigen (CrAg) test was performed in some patients with PC. The diagnostic efficiencies of three methods for PC (mNGS, conventional culture, and CrAg) were compared. Additionally, two mNGS methods were used in this study: original mNGS (OmNGS, testing time from January 2021 to December 2022) and modified mNGS (MmNGS, testing time from January to December 2023). The diagnostic efficiency of the two mNGS methods on PC was simultaneously compared. Results: Among the 321 patients, 23 (7.2%) had PC and 298 (92.8%) did not. Compared with the composite reference standard for PC diagnosis, the sensitivity, specificity, and accuracy of mNGS for PC were 78.3% (95% confidence interval [CI], 55.8%-91.7%), 98.7% (95% CI, 96.4%-99.6%), and 97.2% (95% CI, 94.7%-98.7%), respectively. The sensitivity of mNGS was similar to that of CrAg (80.0%, 12/15) (P > 0.05). The diagnostic sensitivity of both mNGS and CrAg was higher than that of conventional culture (35.0%, 7/20) (P = 0.006, P = 0.016), and the combined detection of mNGS and CrAg further improved the diagnostic sensitivity of PC (93.3%, 14/15). The area under the receiver operating characteristic curve of mNGS was superior to that of conventional culture (0.885 vs. 0.675). In addition, the diagnostic sensitivity of PC was higher than that of OmNGS (P = 0.046). Conclusion: The sensitivity of mNGS is better than that of conventional culture. The combination of mNGS and CrAg improves the testing sensitivity of Cryptococcus. MmNGS could further improve the detection of Cryptococcus. Conventional PC detection methods are indispensable and mNGS can be used as a rapid and accurate auxiliary diagnostic method for PC.
引用
收藏
页数:14
相关论文
共 51 条
  • [1] Disseminated cryptococcosis in a patient with idiopathic CD4+T lymphocytopenia presenting as prostate and adrenal nodules: diagnosis from pathology and mNGS, a case report
    Baomo, Liu
    Guofen, Zeng
    Jie, Dong
    Liu, Xie
    Shuru, Chen
    Jing, Liu
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [2] Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkw1070, 10.1093/nar/gkp1024, 10.1093/nar/gkl986, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkg057]
  • [3] Bialek R, 2002, AM J CLIN PATHOL, V117, P597
  • [4] Dueling in the lung: how Cryptococcus spores race the host for survival
    Botts, Michael R.
    Hull, Christina M.
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2010, 13 (04) : 437 - 442
  • [5] Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
    Chang, Christina C.
    Harrison, Thomas S.
    Bicanic, Tihana A.
    Chayakulkeeree, Methee
    Sorrell, Tania C.
    Warris, Adilia
    Hagen, Ferry
    Spec, Andrej
    Oladele, Rita
    Govender, Nelesh P.
    Chen, Sharon C.
    Mody, Christopher H.
    Groll, Andreas H.
    Chen, Yee-Chun
    Lionakis, Michail S.
    Alanio, Alexandre
    Castaneda, Elizabeth
    Lizarazo, Jairo
    Vidal, Jose E.
    Takazono, Takahiro
    Hoenigl, Martin
    Alffenaar, Jan-Willem
    Gangneux, Jean-Pierre
    Soman, Rajeev
    Zhu, Li-Ping
    Bonifaz, Alexandro
    Jarvis, Joseph N.
    Day, Jeremy N.
    Klimko, Nikolai
    Salmanton-Garcia, Jon
    Jouvion, Gregory
    Meya, David B.
    Lawrence, David
    Rahn, Sebastian
    Bongomin, Felix
    McMullan, Brendan J.
    Sprute, Rosanne
    Nyazika, Tinashe K.
    Beardsley, Justin
    Carlesse, Fabianne
    Heath, Christopher H.
    Ayanlowo, Olusola O.
    Mashedi, Olga M.
    Queiroz-Telles Filho, Flavio
    Hosseinipour, Mina C.
    Patel, Atul K.
    Temfack, Elvis
    Singh, Nina
    Cornely, Oliver A.
    Boulware, David R.
    [J]. LANCET INFECTIOUS DISEASES, 2024, 24 (08) : e495 - e512
  • [6] Chen L A, 2021, Zhonghua Jie He He Hu Xi Za Zhi, V44, P14, DOI 10.3760/cma.j.cn112147-20200122-00034
  • [7] Consensus Group Of Experts On Application Of Metagenomic Next Generation Sequencing In The Pathogen Diagnosis In Clinical Moderate And Severe Infections, 2020, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V32, P531, DOI 10.3760/cma.j.cn121430-20200228-00095
  • [8] Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
    Donnelly, J. Peter
    Chen, Sharon C.
    Kauffman, Carol A.
    Steinbach, William J.
    Baddley, John W.
    Verweij, Paul E.
    Clancy, Cornelius J.
    Wingard, John R.
    Lockhart, Shawn R.
    Groll, Andreas H.
    Sorrell, Tania C.
    Bassetti, Matteo
    Akan, Hamdi
    Alexander, Barbara D.
    Andes, David
    Azoulay, Elie
    Bialek, Ralf
    Bradsher, Robert W., Jr.
    Bretagne, Stephane
    Calandra, Thierry
    Caliendo, Angela M.
    Castagnola, Elio
    Cruciani, Mario
    Cuenca-Estrella, Manuel
    Decker, Catherine F.
    Desai, Sujal R.
    Fisher, Brian
    Harrison, Thomas
    Heussel, Claus Peter
    Jensen, Henrik E.
    Kibbler, Christopher C.
    Kontoyiannis, Dimitrios P.
    Kullberg, Bart-Jan
    Lagrou, Katrien
    Lamoth, Frederic
    Lehrnbecher, Thomas
    Loeffler, Jurgen
    Lortholary, Olivier
    Maertens, Johan
    Marchetti, Oscar
    Marr, Kieren A.
    Masur, Henry
    Meis, Jacques F.
    Morrisey, C. Orla
    Nucci, Marcio
    Ostrosky-Zeichner, Luis
    Pagano, Livio
    Patterson, Thomas F.
    Perfect, John R.
    Racil, Zdenek
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1367 - 1376
  • [9] Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection
    Gu, Wei
    Miller, Steve
    Chiu, Charles Y.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14, 2019, 14 : 319 - 338
  • [10] Metagenomic next generation sequencing of bronchoalveolar lavage samples for the diagnosis of lower respiratory tract infections: A systematic review and meta-analysis
    Guo, Qiang
    Xiao, Yang
    Zhang, Shihai
    [J]. HELIYON, 2024, 10 (01)